Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01246063 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: carfilzomib
DRUG: pegylated liposomal doxorubicin (PLD)
DRUG: Dexamethasone

Sponsor

Washington University School of Medicine